CRISPR-targeting produced a point mutation that results in the amino acid substitution of glutamic acid with lysine at position 1132 (E1132K), which is equivalent to E1124 in human patients with midline brain defects. (J:296537)
查看原文 参与反馈
CRISPR-targeting produced a point mutation that results in the amino acid substitution of glutamic acid with lysine at position 1132 (E1132K), which is equivalent to E1124 in human patients with midline brain defects. (J:296537)